1,133
Views
40
CrossRef citations to date
0
Altmetric
Research Article

Mammography activity in Norway 1983 to 2008

, , , , , & show all
Pages 1062-1067 | Received 19 Apr 2011, Accepted 17 Jun 2011, Published online: 11 Aug 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Peer Christiansen, Ilse Vejborg, Niels Kroman, Iben Holten, Jens Peter Garne, Peter Vedsted, Susanne Møller & Elsebeth Lynge. (2014) Position paper: Breast cancer screening, diagnosis, and treatment in Denmark. Acta Oncologica 53:4, pages 433-444.
Read now

Articles from other publishers (39)

Torunn Heggland, Lars Johan Vatten, Signe Opdahl & Harald Weedon-Fekjær. (2023) Non-progressive breast carcinomas detected at mammography screening: a population study. Breast Cancer Research 25:1.
Crossref
N. Moshina, R.S. Falk & S. Hofvind. (2021) Long-term quality of life among breast cancer survivors eligible for screening at diagnosis: a systematic review and meta-analysis. Public Health 199, pages 65-76.
Crossref
Harald Weedon-Fekjær, Xiaoxue Li & Sandra Lee. (2020) Estimating the natural progression of non-invasive ductal carcinoma in situ breast cancer lesions using screening data. Journal of Medical Screening 28:3, pages 302-310.
Crossref
Marthe Larsen, Nataliia Moshina, Silje Sagstad & Solveig Hofvind. (2020) Factors associated with attendance and attendance patterns in a population-based mammographic screening program. Journal of Medical Screening 28:2, pages 169-176.
Crossref
Laura Steponavičienė, Rūta Briedienė, Rasa Vansevičiūtė-Petkevičienė, Daiva Gudavičienė & Ieva Vincerževskienė. (2020) Breast cancer screening program in Lithuania: trends in breast cancer mortality before and during the introduction of the mammography screening programme. Acta medica Lituanica 27:2, pages 61-69.
Crossref
Åsne Holen, Sofie Sebuødegård, Gunvor G Waade, Hildegunn Aase, Nina-Merete Hopland, Kristin Pedersen, Marthe Larsen, Kaitlyn M Tsuruda & Solveig Hofvind. (2019) Screening at stationary versus mobile units in BreastScreen Norway. Journal of Medical Screening 27:1, pages 31-39.
Crossref
Mette H. Møller, Mette Lise Lousdal, Ivar S. Kristiansen & Henrik Støvring. (2019) Effect of organized mammography screening on breast cancer mortality: A population-based cohort study in Norway. International Journal of Cancer 144:4, pages 697-706.
Crossref
José Antonio Baeyens-Fernández, Elena Molina-Portillo, Marina Pollán, Miguel Rodríguez-Barranco, Rosario Del Moral, Lorenzo Arribas-Mir, Emilio Sánchez-Cantalejo Ramírez & María-José Sánchez. (2018) Trends in incidence, mortality and survival in women with breast cancer from 1985 to 2012 in Granada, Spain: a population-based study. BMC Cancer 18:1.
Crossref
Åsbjørn Schumacher Westvik, Harald Weedon-Fekjær, Jan Mæhlen & Knut Liestøl. (2018) Evaluating different breast tumor progression models using screening data. BMC Cancer 18:1.
Crossref
Eiliv Lund, Aurelie Nakamura & Jean-Christophe Thalabard. (2018) No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer study. European Journal of Cancer 89, pages 102-112.
Crossref
Valérie D.V. Sankatsing, Nicolien T. van Ravesteyn, Eveline A.M. Heijnsdijk, Caspar W.N. Looman, Paula A. van Luijt, Jacques Fracheboud, Gerard J. den Heeten, Mireille J.M. Broeders & Harry J. de Koning. (2017) The effect of population-based mammography screening in Dutch municipalities on breast cancer mortality: 20 years of follow-up. International Journal of Cancer 141:4, pages 671-677.
Crossref
Paula A van Luijt, Eveline AM Heijnsdijk, Nicolien T van Ravesteyn, Solveig Hofvind & Harry J de Koning. (2016) Breast cancer incidence trends in Norway and estimates of overdiagnosis. Journal of Medical Screening 24:2, pages 83-91.
Crossref
Stephen Morrell, Richard Taylor, David Roder, Bridget Robson, Marli Gregory & Kirsty Craig. (2017) Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999–2011. British Journal of Cancer 116:6, pages 828-839.
Crossref
P.A. van Luijt, E.A.M. Heijnsdijk & H.J. de Koning. (2017) Cost-effectiveness of the Norwegian breast cancer screening program. International Journal of Cancer 140:4, pages 833-840.
Crossref
Alfonso Frigerio, Francesco Sardanelli & Franca Podo. 2017. Breast Cancer. Breast Cancer 171 203 .
Solveig Hofvind, Marta Román, Sofie Sebuødegård & Ragnhild S Falk. (2016) Balancing the benefits and detriments among women targeted by the Norwegian Breast Cancer Screening Program. Journal of Medical Screening 23:4, pages 203-209.
Crossref
Marit Valla, Lars Johan Vatten, Monica Jernberg Engstrøm, Olav Anton Haugen, Lars Andreas Akslen, Johan Håkon Bjørngaard, Anne Irene Hagen, Borgny Ytterhus, Anna Mary Bofin & Signe Opdahl. (2016) Molecular Subtypes of Breast Cancer: Long-term Incidence Trends and Prognostic Differences. Cancer Epidemiology, Biomarkers & Prevention 25:12, pages 1625-1634.
Crossref
Søren T. Klitkou. (2016) The impacts of public mammography screening on the relationship between socioeconomic status and cancer stage. SSM - Population Health 2, pages 502-511.
Crossref
Tron A. Moger, Gudrun M. W. Bjørnelv & Eline Aas. (2015) Expected 10-year treatment cost of breast cancer detected within and outside a public screening program in Norway. The European Journal of Health Economics 17:6, pages 745-754.
Crossref
Mette L Lousdal, Ivar S Kristiansen, Bjørn Møller & Henrik Støvring. (2016) Effect of organised mammography screening on stage-specific incidence in Norway: population study. British Journal of Cancer 114:5, pages 590-596.
Crossref
Sofie Sebuødegård, Silje Sagstad & Solveig Hofvind. (2016) Oppmøte i Mammografiprogrammet. Tidsskrift for Den norske legeforening 136:17, pages 1448-1451.
Crossref
Daniel B. Kopans. (2015) An open letter to panels that are deciding guidelines for breast cancer screening. Breast Cancer Research and Treatment 151:1, pages 19-25.
Crossref
Sune Bangsbøll Andersen, Sven Törnberg, Elsebeth Lynge, My Von Euler-Chelpin & Sisse Helle Njor. (2014) A simple way to measure the burden of interval cancers in breast cancer screening. BMC Cancer 14:1.
Crossref
Mette L. Lousdal, Ivar S. Kristiansen, Bjørn Møller & Henrik Støvring. (2014) Trends in breast cancer stage distribution before, during and after introduction of a screening programme in Norway. European Journal of Public Health 24:6, pages 1017-1022.
Crossref
Daniel B. Kopans, Matthew L. Webb & Blake Cady. (2014) The 20-year effort to reduce access to mammography screening: Historical facts dispute a commentary in Cancer . Cancer 120:18, pages 2792-2799.
Crossref
Veronica L. Irvin & Robert M. Kaplan. (2014) Screening Mammography & Breast Cancer Mortality: Meta-Analysis of Quasi-Experimental Studies. PLoS ONE 9:6, pages e98105.
Crossref
Daniel B. Kopans. (2014) Arguments Against Mammography Screening Continue to be Based on Faulty Science. The Oncologist 19:2, pages 107-112.
Crossref
Ki-Bong Yoo, Jeoung A Kwon, Eun Cho, Moon Hae Kang, Jung-Mo Nam, Kui Son Choi, Eun Kyung Kim, Yun Jeong Choi & Eun-Cheol Park. (2013) Is Mammography for Breast Cancer Screening Cost-Effective in Both Western and Asian Countries?: Results of a Systematic Review. Asian Pacific Journal of Cancer Prevention 14:7, pages 4141-4149.
Crossref
M G Marmot, D G Altman, D A Cameron, J A Dewar, S G Thompson & M Wilcox. (2013) The benefits and harms of breast cancer screening: an independent review. British Journal of Cancer 108:11, pages 2205-2240.
Crossref
Elsebeth Lynge, Sisse H. Njor, Anne Helene Olsen, Marit Waaseth, Tonje Braaten, Eiliv Lund & Merethe Kumle. (2012) Author's reply: Breast cancer mortality in Norway after the introduction of mammography screening. International Journal of Cancer 132:7, pages 1727-1727.
Crossref
Karsten Juhl Jørgensen, John Brodersen & Peter C. Gøtzsche. (2012) Thirteen years of breast screening had no measurable effect on breast cancer mortality in Norway. International Journal of Cancer 132:7, pages 1725-1726.
Crossref
Mette Kalager, Magnus Løberg & Michael Bretthauer. (2012) Limited use of nonprogram screening in Norway. International Journal of Cancer 132:7, pages 1723-1724.
Crossref
Anne Helene Olsen, Elsebeth Lynge, Sisse H. Njor, Merethe Kumle, Marit Waaseth, Tonje Braaten & Eiliv Lund. (2013) Breast cancer mortality in Norway after the introduction of mammography screening. International Journal of Cancer 132:1, pages 208-214.
Crossref
Solveig R Hoff, Olbjørn Klepp & Solveig Hofvind. (2012) Asymptomatic Breast Cancer in Non-Participants of the National Screening Programme in Norway: A Confounding Factor in Evaluation?. Journal of Medical Screening 19:4, pages 177-183.
Crossref
Sisse Njor, Lennarth Nyström, Sue Moss, Eugenio Paci, Mireille Broeders, Nereo Segnan & Elsebeth Lynge. (2012) Breast Cancer Mortality in Mammographic Screening in Europe: A Review of Incidence-Based Mortality Studies. Journal of Medical Screening 19:1_suppl, pages 33-41.
Crossref
Sm Moss, L Nyström, H Jonsson, E Paci, E Lynge, S Njor & M Broeders. (2012) The Impact of Mammographic Screening on Breast Cancer Mortality in Europe: A Review of Trend Studies. Journal of Medical Screening 19:1_suppl, pages 26-32.
Crossref
Mireille Broeders, Sue Moss, Lennarth Nyström, Sisse Njor, Håkan Jonsson, Ellen Paap, Nathalie Massat, Stephen Duffy, Elsebeth Lynge & Eugenio Paci. (2012) The Impact of Mammographic Screening on Breast Cancer Mortality in Europe: A Review of Observational Studies. Journal of Medical Screening 19:1_suppl, pages 14-25.
Crossref
Solveig Hofvind, Christoph I. Lee & Joann G. Elmore. (2012) Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program. Breast Cancer Research and Treatment 135:1, pages 291-299.
Crossref
Per Skaane. (2011) Controversies in mammography screening: let us not ignore science in this never-ending debate. Acta Radiologica 52:10, pages 1061-1063.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.